Cargando…

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

Detalles Bibliográficos
Autores principales:	Maure, Christine G, Dodoo, Alexander N, Bonhoeffer, Jan, Zuber, Patrick LF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2014
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208577/ https://www.ncbi.nlm.nih.gov/pubmed/25378762 http://dx.doi.org/10.2471/BLT.14.138875

Ejemplares similares

Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project
por: Sharan, Apoorva, et al.
Publicado: (2022)

Evolving pharmacovigilance requirements with novel vaccines and vaccine components
por: Zuber, Patrick L F, et al.
Publicado: (2021)

A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals
por: Stergachis, Andy, et al.
Publicado: (2010)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

Potential Immunologic and Integrative Methods to Enhance Vaccine Safety
por: Dattner, Alan M.
Publicado: (2022)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Intussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India
por: Das, Manoja Kumar, et al.
Publicado: (2018)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013
por: Diomandé, Fabien V. K., et al.
Publicado: (2015)

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences
por: Hilda Ampadu, H., et al.
Publicado: (2018)

Pharmacovigilance and assessment of drug safety reports during COVID 19
por: Desai, Mira K
Publicado: (2020)

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015()
por: Lei, Jiayao, et al.
Publicado: (2018)

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
por: Falzon, Dennis, et al.
Publicado: (2014)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
por: Sullivan, John T.
Publicado: (2022)

Strengthening Africa’s capacity for vaccine research: Needs and challenges
por: Owolade, Adedoyin John-Joy, et al.
Publicado: (2022)

Addressing production gaps for vaccines in African countries
por: Ekström, Anna Mia, et al.
Publicado: (2021)

Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition"
por: Hauben, Manfred, et al.
Publicado: (2020)

Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions
por: Munoz, Flor M., et al.
Publicado: (2015)

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
por: Chandler, Rebecca E.
Publicado: (2017)

Role of Pharmacovigilance on Vaccines Control*
por: Kuçuku, Merita
Publicado: (2012)

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
por: Cervantes, Jorge L, et al.
Publicado: (2018)

Progress of Active Surveillance for Vaccine Safety in China
por: Liu, Zhike, et al.
Publicado: (2021)

The Importance of Active Surveillance in the Assessment of Vaccine Safety
por: Black, Steven
Publicado: (2019)

Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021)

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021)

Dilemmas of evaluation: health research capacity initiatives
por: Cole, Donald C, et al.
Publicado: (2014)

COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022)

Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021)

COVID-19 vaccines: Global challenges and prospects forum recommendations
por: Boudjelal, Mohamed, et al.
Publicado: (2021)

Achieving Global Vaccine Equity: The Case for an International Pandemic Treaty
por: Jecker, Nancy S.
Publicado: (2022)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Safety of routine childhood vaccine coadministration versus separate vaccination
por: Bauwens, Jorgen, et al.
Publicado: (2022)

Capacity Building in Global Mental Health Research
por: Thornicroft, Graham, et al.
Publicado: (2012)

Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011)

Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries
por: Mukherjee, Sanjana, et al.
Publicado: (2023)

Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic
por: Oehler, Richard L, et al.
Publicado: (2021)

China’s COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic
por: Meng, Zhigang, et al.
Publicado: (2021)

The world needs BRICS countries to build capacity in invasion science
por: Measey, John, et al.
Publicado: (2019)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c20d3rqp6ffndibbeqv8qa9c7h